Fecal Microbiota Transplant for Patients With Recurring C. Diff
Fecal Microbiota Transplant (FMT) has emerged as a successful treatment for patients with Clostridium difficile, commonly known as C. diff, given the therapy’s approximate 90 percent effective rate.
This therapy is offered at Baylor Scott & White All Saints Medical Center – Fort Worth and now at Baylor Scott & White Medical Center – Carrollton.
FMT is a minimally invasive, same-day procedure that places the stool from a healthy person into the GI tract of an infected individual to repopulate the gut with healthy bacteria. FMT is performed through endoscopy/enteroscopy or colonoscopy and generally, only one procedure is required.
According to an article published by the American Association of Family Practice in April 2012, Clostridium difficile Infection Incidence, Costs Reach Historic Highs, the incidence of C. diff has tripled over the past decade.
Benefits of FMT
Candidates for FMT
Patients with documented recurrence of C. diff through repeat stool studies post-antibiotic therapy are candidates for FMT.
Refer a Patient
Search for a gastroenterologist online who performs FMT, or call 1-800-9BAYLOR.